Loading...
•
Jun 30, 2021
ICU Medical Q2 2021 Earnings Report
ICU Medical's second quarter results were generally in line with expectations, with revenue increasing compared to the same period last year.
Key Takeaways
ICU Medical announced its second quarter 2021 results, with revenue reaching $321.7 million compared to $303.4 million in the same period last year. GAAP net income was $28.4 million, or $1.31 per diluted share, compared to $18.9 million, or $0.88 per diluted share, for the second quarter of 2020. The company updated its full year 2021 guidance for adjusted EBITDA and adjusted diluted earnings per share.
Second quarter revenue was $321.7 million, up from $303.4 million in the same period last year.
GAAP gross profit for the second quarter was $123.5 million, compared to $106.3 million in the same period last year.
GAAP net income for the second quarter was $28.4 million, or $1.31 per diluted share, compared to $18.9 million, or $0.88 per diluted share, for the second quarter of 2020.
Adjusted diluted earnings per share for the second quarter were $1.88, compared to $1.65 for the second quarter of 2020.
Revenue by Segment
Forward Guidance
The company is updating its full year 2021 guidance of adjusted EBITDA from a range of $245 million to $265 million to a range of $250 million to $260 million and adjusted diluted earnings per share from a range of $6.50 to $7.20 to a range of $6.80 to $7.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...